In addition, when melanomas are classified into BRAF‐mutant, RAS‐mutant, NF1‐loss, and triple wild type,19 about half of CM cases have BRAF mutations, while only 10%–20% of AM and MM cases have them.17, 20. This evidence concerns the gene BRAF and Miyoshi myopathy.